JP2839126B2 - Branched artificial blood vessel - Google Patents

Branched artificial blood vessel

Info

Publication number
JP2839126B2
JP2839126B2 JP14375293A JP14375293A JP2839126B2 JP 2839126 B2 JP2839126 B2 JP 2839126B2 JP 14375293 A JP14375293 A JP 14375293A JP 14375293 A JP14375293 A JP 14375293A JP 2839126 B2 JP2839126 B2 JP 2839126B2
Authority
JP
Japan
Prior art keywords
blood vessel
artificial blood
crotch
branched
branch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP14375293A
Other languages
Japanese (ja)
Other versions
JPH07428A (en
Inventor
靖 城
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ube Corp
Original Assignee
Ube Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ube Industries Ltd filed Critical Ube Industries Ltd
Priority to JP14375293A priority Critical patent/JP2839126B2/en
Publication of JPH07428A publication Critical patent/JPH07428A/en
Application granted granted Critical
Publication of JP2839126B2 publication Critical patent/JP2839126B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、2支ないし3支あるい
はそれ以上の多支人工血管における分岐部分に発生する
漏血を完璧に防止しうる枝分かれ人工血管の改良に関す
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an improved bifurcated vascular prosthesis capable of completely preventing blood leakage occurring at a bifurcation of a bifurcated or triprosthetic vascular prosthesis.

【0002】[0002]

【従来の技術及びその問題点】人工血管の歴史は実用化
されて早くも30余年に達する。とりわけポリエステル
人工血管、延伸弗化樹脂よりなる人工血管は優れたもの
として世界で使用実績をあげつつある。これらの人工血
管は、いずれもその管壁が空隙性に富み、移植後にその
内表面に内皮細胞が生長し生体化して、本来の血管の代
用となるものである。その空隙が人工血管の生体化に重
要な役割を果たすものと考えられてきた。
2. Description of the Related Art The history of artificial blood vessels reaches more than 30 years as soon as they have been put to practical use. In particular, polyester artificial blood vessels and artificial blood vessels made of stretched fluororesin are being used in the world as excellent ones. In these artificial blood vessels, the tube wall is rich in porosity, and endothelial cells grow on the inner surface of the artificial blood vessel after transplantation and become a living body, thereby substituting the original blood vessel. It has been thought that the void plays an important role in the bioartificialization of the artificial blood vessel.

【0003】通常、人工血管は最初は直線状のチューブ
が用いられてきたが、複雑な血行動態に対応して、体中
を網羅して張りめぐらされている生体血管の一部を代用
するには、血管病変部が一か所のみに存在するときは、
直線状の人工血管は極めて便利である。しかし、一般に
血管に病変をもつ人には、複数の病変部がみられること
が多い。
[0003] Normally, a straight tube has been used as an artificial blood vessel at first. However, in order to cope with complicated hemodynamics, it is necessary to substitute a part of a living blood vessel which is stretched all over the body. Means that when a vascular lesion exists in only one place,
Straight vascular prostheses are very convenient. However, in general, a person having a lesion in a blood vessel often has a plurality of lesions.

【0004】このような場合、病変部を置換したり、あ
るいは病変部をそのままにしてバイパスをつくって血流
を正常に確保したりするのであるが、この場合には、枝
分かれ人工血管を用いると、ひとつの人工血管で複数の
病変部の処置ができるのでまことに便利である。生体血
管の病変のうち、動脈瘤のような危険な場合は、その部
分を人工血管で完全に遮断してバイパスをつくることが
ある。また、生体血管の本来枝分かれしている部分が動
脈瘤を形成しているときは、当然、枝分かれ人工血管が
要求される。さらに、生体血管の閉塞や狭窄が複数ヶ所
ある場合も、枝分かれ人工血管があれば極めて便利であ
る。
In such a case, the diseased part is replaced, or the diseased part is left as it is to create a bypass to secure a normal blood flow. In this case, a branched artificial blood vessel is used. It is very convenient because a plurality of lesions can be treated with one artificial blood vessel. In the case of a dangerous lesion such as an aneurysm in a living vascular lesion, a bypass may be created by completely blocking the portion with an artificial blood vessel. Further, when an originally branched portion of a living blood vessel forms an aneurysm, a branched artificial blood vessel is naturally required. Further, when there are a plurality of occlusions and stenosis of a living blood vessel, it is extremely convenient if there is a branched artificial blood vessel.

【0005】医師の施術面でも、線状血管を2本用いて
バイパスをつくる場合、4ヵ所の吻合が必要であるが、
Y字型の人工血管を用いれば3ヵ所の吻合ですむので、
施術労力の減少に効果が大きい。それに伴って、患者の
負担も、安全性や施術時間の短縮によって軽減されるこ
とになるため、その有用性はよく認められている。従っ
て、枝分かれ人工血管が市場に受け入れられていること
は当然であり、Y字形、T字形あるいは分岐2本〜3本
の、2支、3支の枝分かれ人工血管の市場からの要求は
大きい。
[0005] From the point of view of the doctor, when making a bypass using two linear blood vessels, four places of anastomosis are necessary.
If a Y-shaped artificial blood vessel is used, only three anastomoses are needed,
The effect is great in reducing the labor required. Accordingly, its usefulness is well recognized because the burden on the patient can be reduced by safety and shortening of the operation time. Therefore, it is natural that a branched artificial blood vessel is accepted in the market, and there is a great demand from the market for a Y-shaped, T-shaped or two to three bifurcated, three-branched branched artificial blood vessel.

【0006】[0006]

【発明が解決しようとする課題】上述の如く、枝分かれ
人工血管は、施術する医師にとっても、施術を受ける患
者にとっても極めて有用であるが、従来、不可避の問題
点が存在する。これをY字形の人工血管で説明する。図
1に典型的なY字形の人工血管を示した。ここでは、逆
Y字の形の位置関係で示した。すなわち、Aで示した比
較的太い人工血管がBおよびCで示した比較的細い2支
に分かれたものである。施術者やその補助者は滅菌され
たこの枝分かれ人工血管を患者に移植するのであるが、
取扱い中に支管のBとCに矢印で示したような方向に、
誤って僅かな力でも加えると、支管BとCの接点部分
(P点)あるいは股部に力が集中し、この部分の織り目
がBとCの方向に引っ張られて繊維間隔が緩む現象(目
開きという)が生じる。
As described above, a branched artificial blood vessel is extremely useful for both a physician who performs a procedure and a patient who undergoes the procedure. However, there is an unavoidable problem heretofore. This will be described using a Y-shaped artificial blood vessel. FIG. 1 shows a typical Y-shaped artificial blood vessel. Here, the positional relationship is shown in an inverted Y-shape. That is, the relatively thick artificial blood vessel indicated by A is divided into relatively thin bifurcations indicated by B and C. The practitioner and his / her assistant transplant this sterilized branched vascular graft into the patient.
During handling, in the directions indicated by the arrows on the branches B and C,
If a slight force is applied by mistake, the force concentrates on the contact point (point P) or the crotch of the branch pipes B and C, and the texture of this section is pulled in the directions of B and C to loosen the fiber spacing (mesh). Opening).

【0007】この取扱い上の僅かの力のかけ方で、この
部分の目開きが、目視ではほとんど差はなくても、繊維
集合体の織り目がルーズになる弛緩がおこっていること
がある。もちろん、このことは施術者も熟知していて取
扱いに注意を払うものの、取扱い上で支管BとCの間の
力がたまたま加わらないとは限らない。この場合、主管
Aと支管(B又はC)の間に力が加わっても、主管と支
管の股部Q点には力が大きくはかからないが、支管同志
BとCの間で力が矢印方向にかかると、股を裂くように
力が加わって、支管の接触点(股部)の織り目の弛緩は
最もおそれられるところである。これらの可能性は施術
者の取扱い時にもあるが、製造途中で品質管理上のテス
トを充分に行っていても、例えば、そのテスト後に最終
工程の包装時にでも取扱い者の一寸した不注意で支管間
に力が加わり、その股部に織り目の弛緩が生じるおそれ
は皆無といえないのである。そして、一見の目視ではこ
のような弛緩の生起を把握することは極めて困難であ
る。
[0007] Even if the opening of this portion has little difference in visual inspection by applying a slight force in handling, there is a case where the fiber assembly loosens to loosen the texture. Of course, although this is well understood by the practitioner and pays attention to the handling, the force between the branches B and C does not always happen to occur during the handling. In this case, even if a force is applied between the main pipe A and the branch pipe (B or C), a large force is not applied to the crotch point Q between the main pipe and the branch pipe, but the force is applied between the branch pipes B and C in the direction of the arrow. In this case, a force is applied so as to tear the crotch, and the weave of the weave at the contact point (crotch) of the branch pipe is most feared. Although these possibilities may occur during the handling of the practitioner, even if the quality control tests are sufficiently performed during the manufacturing process, for example, even when the final process is packaged after the tests, the caretaker may be inadvertently injured. There is no danger that a force will be applied in the middle and the texture of the crotch will be loosened. Then, it is extremely difficult to grasp the occurrence of such relaxation at first glance.

【0008】一方、このような股部に弛緩を生じている
枝分かれ人工血管を施術者が生体血管に吻合埋植した場
合、術後の血液導入開始によって、この弛緩部の織り目
の目開き部から血液が漏れ、ひどいときには奔出するこ
とがある。これは極めて重大な結果を及ぼすことにな
る。すなわち、患者は生命が脅かされる重篤の事態に直
面し、これが原因となって死の転帰をとることも考えら
れる。
[0008] On the other hand, when a practitioner implants an anastomotic implant into a living blood vessel with such a branched artificial blood vessel in which the crotch portion is relaxed, the blood introduction after the operation starts, the open portion of the texture of the relaxed portion is opened. Blood may leak, and in severe cases it may rush. This has very serious consequences. That is, the patient may be faced with a life-threatening serious condition that may result in death.

【0009】このように枝分かれ人工血管の股部の弛緩
現象は、患者にとって生死を分ける程の大きい問題点を
惹起し、その頻度は細心の品質管理、製造管理を行って
も、この欠点を皆無にすることは難しいのが実情であ
る。また、安全性、有効生の面からこの欠点の皆無を要
求されることは言うまでもない。
As described above, the relaxation of the crotch portion of the branched artificial blood vessel causes a serious problem for the patient, and the frequency of the problem is completely eliminated even if careful quality control and production control are performed. It is actually difficult to do so. Needless to say, it is required to eliminate these disadvantages in terms of safety and effective life.

【0010】[0010]

【課題を解決するための手段】本発明者は、目開きの発
生頻度は綿密な品質管理、品質検査、精緻な製造工程を
もってしても極めて低いとはいえ、いったん惹起すれ
ば、患者を重篤な状況に陥れる枝分かれ人工血管の支管
間、主管−支管の接合点(股部)の織り目の弛緩による
目開きという欠点生起を100%皆無にする方法につい
て鋭意検討を行った結果、この枝分かれ人工血管の僅か
の応力で最も目開きが起こり易い部分に弾性を有する高
分子物質でコーティングを施し、そこに高分子弾性体の
薄膜を形成させ、たとえ枝分かれした股部の編み目がル
ーズに弛緩したとしても完全に漏血をシールすることが
できることを見出し本発明に到達した。
SUMMARY OF THE INVENTION The present inventors have found that the frequency of openings is extremely low even with careful quality control, quality inspection, and precise manufacturing processes. As a result of extensive studies, a method of completely eliminating the occurrence of a defect such as opening caused by loosening of the weave between the branches of the artificial blood vessel and the junction of the main pipe and the branch pipe (the crotch) which falls into a serious situation was examined. Apply a coating of an elastic polymer material to the part of the blood vessel where the opening is most likely to occur with a slight stress, and form a thin film of a polymer elastic material there, even if the stitches of the branched crotch loosen loosely Also found that it was possible to completely seal the blood leak and reached the present invention.

【0011】本発明は、枝分かれを有する人工血管にお
いて、主管より枝分かれした支管間の股点あるいは支管
と主管との付け根の股点を中心に少なくとも支管の直径
の範囲に高分子弾性体をコーティングすることを特徴と
する枝分かれ人工血管に関する。そして、その高分子弾
性体はポリウレタン又はポリシロキサンが好ましい。
According to the present invention, in an artificial blood vessel having a branch, a polymer elastic material is coated on at least the range of the diameter of the branch pipe centered on the crotch point between the branch pipes branched from the main pipe or the crotch point at the base of the branch pipe and the main pipe. The present invention relates to a branched artificial blood vessel. And, the elastic polymer is preferably polyurethane or polysiloxane.

【0012】本発明において、股部とは図1においてP
点(支管間股点)付近であり、Q又はQ’点(主管−支
管股点)付近である。また、図2a,b,cに示すよう
な枝分かれ人工血管の場合も、P点、Q点が股点であ
り、その周辺が股部に相当する。この場合、最も重要な
のは股部の角度が直角ないしそれより小さい部分であっ
て、取扱い者のちょっとした力のかけ方で最も織り目の
目開きがおこり易い部分である。すなわち、図2におい
てそれぞれP点を中心に矢印方向に開くときに最も目開
きが起こり易いのである。
In the present invention, the crotch portion is defined as P in FIG.
It is near the point (interbranch crotch point) and near point Q or Q '(main pipe-branch crotch point). Also, in the case of a branched artificial blood vessel as shown in FIGS. 2A, 2B, and 2C, the points P and Q are the crotch points, and the periphery thereof corresponds to the crotch. In this case, what is most important is a portion where the angle of the crotch is a right angle or smaller, and a portion where the texture is most likely to be opened by a slight force applied by the operator. That is, in FIG. 2, the opening is most likely to occur when opening in the direction of the arrow around the point P.

【0013】本発明の高分子弾性体の塗布物質は本来の
高分子の弾性のために、上述の股部の繊維集合体が目開
きしても、この高分子弾性膜の本質である弾性のために
亀裂が入ることがないので、枝分かれ人工血管に潜在す
る危険度を100%除くことができるのである。
The coating material of the polymer elastic body of the present invention has an elasticity which is an essence of the polymer elastic film even if the above-mentioned crotch fiber assembly is opened due to the inherent elasticity of the polymer. As a result, there is no crack, so that the potential risk of the branched artificial blood vessel can be removed by 100%.

【0014】本発明を実施するに当たって、本発明の高
分子弾性体をコーティングする範囲は、Y字形の枝分か
れ人工血管の場合、主管より分かれた支管の交差する鋭
角形成点、すなわち股点(股部の中心点)を中心に支管
の直径(図3:l )の範囲内、さらに好ましくは l/2
の範囲内でコーティングするのがよい。T字形の枝分か
れ人工血管の場合は、支管の付け根の円周部(図4:股
点P、P’を含んだ支管の円周部分)にコーティングす
るのがよい。その範囲は、股点を含んだ支管の円周に沿
って幅l の範囲内にわたってコーティングするのがよ
い。更に好ましくは l/2の範囲内でコーティングする
のがよい。図5に図4のD−D断面図に点線でコーティ
ング範囲を示した。図6に股点Pを含んで支管の円周に
沿って支管の直径l に対してその l/2の幅でコーティ
ングしたときのコーティング範囲を例示した。コーティ
ング範囲の幅は支管の直径l より大きくする必要度は本
発明の主旨に照らして余り大きくはない。
In practicing the present invention, the area coated with the polymer elastic body of the present invention is, in the case of a Y-shaped branched artificial blood vessel, an acute angle forming point where a branch pipe divided from the main pipe intersects, that is, a crotch point (crotch part). Center point), and within the range of the diameter of the branch pipe (FIG. 3: l), more preferably l / 2
It is good to coat within the range. In the case of a T-shaped branched artificial blood vessel, it is preferable to coat the circumference of the base of the branch pipe (FIG. 4: the circumference of the branch pipe including the crotch points P and P ′). Preferably, the area is coated over a range of width l along the circumference of the branch including the crotch point. More preferably, the coating is performed within the range of l / 2. FIG. 5 shows a coating range by a dotted line in a cross-sectional view taken along the line DD of FIG. FIG. 6 exemplifies a coating range when coating is performed at a width of l / 2 of the diameter l of the branch pipe along the circumference of the branch pipe including the crotch point P. The need to make the width of the coating area larger than the diameter l of the branch is not too great in light of the spirit of the invention.

【0015】本発明の実施に当たって用いられる高分子
弾性体の素材は、生体適合性に優れたものがよく、例え
ば、ポリエーテル型ポリウレタン、ポリエーテル型ポリ
ウレタンウレア、ポリエステル型ポリウレタン、ポリエ
ステル型ポリウレタンウレア、シリコーンで代表される
ポリシロキサン、天然ゴムなどを挙げることができる。
その中でも生体適合性と弾性の点でポリウレタン及びポ
リシロキサンが好ましい。
The material of the elastic polymer used in the practice of the present invention is preferably a material having excellent biocompatibility, such as polyether polyurethane, polyether polyurethane urea, polyester polyurethane, polyester polyurethane urea, and the like. Examples thereof include polysiloxane represented by silicone, and natural rubber.
Among them, polyurethane and polysiloxane are preferable in terms of biocompatibility and elasticity.

【0016】コーティングする高分子弾性体は溶媒に溶
解して使用してもよいが、縮合反応によって上述の弾性
高分子に転換するモノマーあるいはオリゴマー、すなわ
ち、高分子弾性体に変換しうる前駆体を用いコーティン
グ後に重縮合ないし付加重合を行わせて所望の高分子弾
性体に変換してもよい。
The polymer elastic material to be coated may be used after being dissolved in a solvent. However, a monomer or oligomer which is converted into the above-mentioned elastic polymer by a condensation reaction, ie, a precursor which can be converted into a polymer elastic material, is used. After coating, polycondensation or addition polymerization may be carried out to convert to a desired polymer elastic body.

【0017】この高分子弾性体あるいはその前駆体を溶
かす溶媒としては、例えばジメチルホルムアミド、ジメ
チルアセトアミド、ジメチルスルホキシド、テトラヒド
ロフラン及びジオキサンを挙げることができる。また、
前駆体の場合は上記溶媒に加えてアセトン、酢酸メチル
及びジオキサンが挙げられる。
Examples of the solvent for dissolving the elastic polymer or its precursor include dimethylformamide, dimethylacetamide, dimethylsulfoxide, tetrahydrofuran and dioxane. Also,
In the case of a precursor, acetone, methyl acetate, and dioxane may be used in addition to the above solvents.

【0018】尚、本発明のコーティングは、人工血管の
外側あるいは内側に、また両側からコーティングするこ
とができるが、外側からコーティングすることが最も好
ましい。内側にコーティングするとその部分の血液より
の内皮細胞の生着が遅れるおそれがあるからである。
The coating of the present invention can be coated on the outside or inside of the artificial blood vessel or from both sides, but it is most preferable to coat from the outside. This is because coating on the inside may delay the engraftment of endothelial cells from the blood in that portion.

【0019】本発明の実施において適用される人工血管
の種類は、ポリエステル系のウーブン人工血管、ニット
人工血管、弗素樹脂の延伸体からなる人工血管又はポリ
ウレタン人工血管などがあるが、本発明の原理に照らし
て、その種類を特に限定するものではない。
The types of artificial blood vessels applied in the practice of the present invention include a polyester woven artificial blood vessel, a knit artificial blood vessel, an artificial blood vessel made of a stretched fluororesin, and a polyurethane artificial blood vessel. In light of the above, the type is not particularly limited.

【0020】[0020]

【発明の効果】本発明により、2支、3支又は4支とい
うように多支人工血管の枝分かれの付け根、股部にあた
る部分に、高分子弾性体でコーティングし、その部分に
弾性高分子の薄膜を形成させことにより、従来から懸案
の問題であった最も目開きを起こし易い部分の繊維間の
弛緩による漏血トラブルを完全に防止し、その安全性を
確固たるものにした。
According to the present invention, a portion corresponding to the bifurcation, such as a bifurcation, a trifurcation or a quadruple, which corresponds to the base of the branch and the crotch, is coated with an elastic polymer, and the elastic polymer is applied to that part. By forming the thin film, the blood leakage trouble due to the loosening between the fibers in the portion where the opening is most likely to occur, which has been a problem in the past, has been completely prevented, and its safety has been secured.

【0021】次に実施例によって本発明を更に具体的に
説明するが、本発明がこれらの実施例に限定されるもの
ではない。
Next, the present invention will be described more specifically with reference to examples, but the present invention is not limited to these examples.

【実施例】【Example】

実施例1 図1に示すY字形の枝分かれ人工血管で、主管(太い部
分)の直径(L)が28mm、支管の直径(l) が14m
mのポリエステル人工血管の股部の中心点(P)の周り
に半径4mmの範囲内にポリエーテルポリウレタン溶液
(濃度12%、溶媒テトラヒドロフラン)を外側からコ
ーティングし、2時間乾燥した。これによってポリエー
テルポリウレタンは股部に薄くコーティング出来た。用
いたポリエーテルポリウレタンは、ポリテトラメチレン
グリコールとジフェニルメチレンジイソシアネートより
つくったプレポリマーをブタンジオールで鎖延長を行っ
たものである。上記処理した図1の人工血管を、2つの
支管を股裂きするように力を加えて股部が目開きするよ
うに引っ張った。これに牛血を圧入、260mmHgに
加圧した状態で1時間放置した。その結果、股部より血
液の漏血も奔出も全くなかった。
Example 1 A Y-shaped branched artificial blood vessel shown in FIG. 1, having a main pipe (thick portion) having a diameter (L) of 28 mm and a branch pipe having a diameter (l) of 14 m
A polyether polyurethane solution (concentration: 12%, solvent: tetrahydrofuran) was coated from the outside around a center point (P) of the crotch portion of the polyester artificial blood vessel having a radius of 4 mm and dried for 2 hours. As a result, a thin coat of polyether polyurethane could be applied to the crotch. The polyether polyurethane used is a prepolymer made from polytetramethylene glycol and diphenylmethylene diisocyanate and subjected to chain extension with butanediol. The treated artificial blood vessel of FIG. 1 was pulled so as to open the crotch by applying a force so as to tear the two branches into the crotch. Bovine blood was injected into this and left for 1 hour in a state of being pressurized to 260 mmHg. As a result, there was no blood leakage or outbreak from the crotch.

【0022】比較例1 一方、ポリエーテルウレタンコーティングを行わない以
外は実施例1と全く同様の条件で操作を行った結果、股
裂きによる目開きにより股部より血液が線状に奔出し
た。
Comparative Example 1 On the other hand, the operation was carried out under exactly the same conditions as in Example 1 except that the polyether urethane coating was not carried out. As a result, blood flowed linearly from the crotch due to the opening due to the cleft.

【0023】実施例2 図4に示すT字形に分岐したポリエステルのウーブン人
工血管の枝分かれ部にポリエーテルウレタンウレア溶液
(濃度13%、溶媒ジメチルホルムアミド)を、当該人
工血管の外壁にコーティングし、60℃で8時間乾燥を
行い所望の部分にポリエーテルウレタンウレアの薄膜を
形成させた。その薄膜はポリエステル人工血管の繊維集
合体にも浸入した剥離しにくい安定した状態であった。
用いた人工血管の主管(太い部分)は12mm、側管
(支管)は8mmであった。コーティングは図4に示す
股点P,P’を含む側管の円周を中心に幅4mmにわた
ってコーティングした。用いたポリエーテルポリウレタ
ンは、ポリテトラメチレングリコールとジフェニルメチ
レンジイソシアネートより調製したプレポリマーをエチ
レンジアミンで鎖延長したものである。上記処理を施し
た図4のT字形人工血管の側管(支管)を主管の延長方
向に股部が目開きするように10回交互に引っ張った。
これに牛血を圧入、280及び500mmHgに加圧で
1時間放置した。その結果、股部P点付近からの血液の
漏血も奔出も全く認められなかった。
Example 2 A polyether urethane urea solution (concentration: 13%, solvent: dimethylformamide) was coated on the branched portion of a T-shaped branched woven artificial blood vessel shown in FIG. Drying was performed at 8 ° C. for 8 hours to form a polyether urethane urea thin film on a desired portion. The thin film was in a stable state, infiltrating into the fiber aggregate of the polyester artificial blood vessel, and hard to peel off.
The main tube (thick portion) of the artificial blood vessel used was 12 mm, and the side tube (branch) was 8 mm. The coating was applied over a width of 4 mm around the circumference of the side tube including the crotch points P and P 'shown in FIG. The polyether polyurethane used was obtained by extending a prepolymer prepared from polytetramethylene glycol and diphenylmethylene diisocyanate with ethylenediamine. The side tube (branch tube) of the T-shaped vascular prosthesis of FIG. 4 subjected to the above-described processing was alternately pulled ten times in the extension direction of the main tube so that the crotch part was opened.
Bovine blood was injected into this and left at 280 and 500 mmHg under pressure for 1 hour. As a result, neither blood leakage nor bleeding near the crotch point P was observed.

【0024】比較例2 ポリエーテルポリウレタンでコーティングしない以外は
実施例2と同様の操作を行った結果、280mmHg加
圧の場合は股部のP点付近よりかなりの漏血が認めら
れ、500mmHgに加圧すると血液が線状に奔出し
た。
Comparative Example 2 The same operation as in Example 2 was performed except that the coating was not performed with the polyether polyurethane. As a result, when the pressure was 280 mmHg, a considerable blood leak was observed from around the point P of the crotch, and the pressure increased to 500 mmHg. When pressed, the blood burst out linearly.

【0025】実施例3 図6に示す(A)及び(B)の形に分岐したポリエステ
ルのウーブン人工血管の枝分かれ部のP点付近にメチル
トリアセトキシランとジメチルジアセトキシシラン
(7:3)溶液(濃度22%、溶媒テトラヒドロフラ
ン)を、当該人工血管の外壁にコーティングし、そのま
ま風乾し、さらに相対湿度65%雰囲気中に1週間放置
した。この間に雰囲気中の水分と反応して酢酸を放出し
ながら縮合が進み、股点Pを中心にポリシロキサンの縮
合物によるコーティングが完成した。用いた人工血管の
主管(太い部分)は20mm、側管(支管)は12mm
であった。コーティングは図6に示す股点Pを中心に直
径8mmの円内にコーティングした。上記処理を施した
図6のT字形人工血管の側管(支管)を主管の延長方向
に股部が目開きするように10回交互に引っ張った。こ
れに牛血を圧入、260mmHgに加圧で1時間放置し
た。その結果、股部P点付近からの血液の漏血も奔出も
全く認められなかった。
Example 3 A solution of methyltriacetoxysilane and dimethyldiacetoxysilane (7: 3) near point P of a branched portion of a woven artificial blood vessel made of polyester branched in the forms (A) and (B) shown in FIG. (Concentration: 22%, solvent: tetrahydrofuran) was coated on the outer wall of the artificial blood vessel, air-dried as it was, and further left in an atmosphere of 65% relative humidity for one week. During this time, condensation proceeded while reacting with moisture in the atmosphere to release acetic acid, and coating with a condensate of polysiloxane was completed around the crotch point P. The main tube (thick part) of the artificial blood vessel used was 20 mm, and the side tube (branch) was 12 mm
Met. The coating was performed within a circle having a diameter of 8 mm centered on the crotch point P shown in FIG. The side tube (branch tube) of the T-shaped vascular prosthesis of FIG. 6 which has been subjected to the above processing was alternately pulled ten times in the extension direction of the main tube so that the crotch part was opened. Bovine blood was injected into this, and left at 260 mmHg for 1 hour. As a result, neither blood leakage nor bleeding near the crotch point P was observed.

【0026】比較例3 実施例3と同様のコーティングをしない以外は実施例3
と同様の操作を行った結果、股部P点付近を中心に顕著
な漏血が認められた。
Comparative Example 3 Example 3 except that the same coating as in Example 3 was not performed.
As a result, a remarkable blood leak was observed around the crotch point P.

【0027】実施例4 図6に示す(A)及び(B)の形に分岐したポリエステ
ル人工血管において、(A)のP点、(B)のP点及び
Q点を含む側管(支管)の円周線に沿って、幅が側管の
径にほぼ等しい範囲内(図5の斜線で示した範囲内)
に、分子量2000の末端水酸基のジメチルポリシロキ
サンとメチルトリアセトキシシランの混合物(8:2)
溶液(濃度20%、テトラヒドロフラン−ジオキサン
(2:1)混合溶媒)を、当該人工血管の外壁にコーテ
ィングし、相対湿度60%雰囲気中に2週間放置した。
この間にメチルジアセトキシシランは雰囲気中の水分と
反応して酢酸を放出しながら縮合が進み、ポリジメチル
シロキサンの両末端の水酸基と縮合し、高分子のポリジ
メチルシロキサンとなりコーティングが完成した。用い
た人工血管の主管(太い部分)は16mm、側管(支
管)は8mmであった。上記とは別に、コーティングを
図6に示す股点Pを中心に直径5mmの円内にコーティ
ングした。上記処理を施した図6のT字形人工血管の側
管(支管)を主管の延長方向に股部が目開きするように
10回交互に引っ張った。これに牛血を圧入、280m
mHgに加圧で1時間放置した。その結果、股部P点付
近からの血液の漏血も奔出も全く認められなかった。
Example 4 In a polyester artificial blood vessel branched into the shapes (A) and (B) shown in FIG. 6, a side tube (branch) including the points P in (A), the points P and Q in (B). Along the circumference of (a), the width is approximately equal to the diameter of the side pipe (within the hatched area in FIG. 5).
A mixture of dimethylpolysiloxane having a molecular weight of 2000 and having terminal hydroxyl groups and methyltriacetoxysilane (8: 2)
A solution (concentration: 20%, mixed solvent of tetrahydrofuran-dioxane (2: 1)) was coated on the outer wall of the artificial blood vessel, and left in an atmosphere of 60% relative humidity for 2 weeks.
During this time, methyl diacetoxysilane reacted with moisture in the atmosphere to release acetic acid, and condensation proceeded, and condensed with hydroxyl groups at both ends of polydimethylsiloxane to form a high molecular weight polydimethylsiloxane, completing the coating. The main tube (thick portion) of the artificial blood vessel used was 16 mm, and the side tube (branch) was 8 mm. Separately from the above, the coating was applied in a circle having a diameter of 5 mm around the crotch point P shown in FIG. The side tube (branch tube) of the T-shaped vascular prosthesis of FIG. 6 subjected to the above processing was alternately pulled ten times in the extension direction of the main tube so that the crotch part was opened. Inject bovine blood into this, 280m
It was left under mHg under pressure for 1 hour. As a result, neither blood leakage nor bleeding near the crotch point P was observed.

【0028】比較例4 実施例4と同様のコーティングをしない以外は実施例4
と同様の操作を行った結果、股部P点付近を中心に著し
い漏血が観察された。
Comparative Example 4 Example 4 except that the same coating as in Example 4 was not performed.
As a result, remarkable blood leakage was observed mainly around the point P of the crotch.

【0029】[0029]

【図面の簡単な説明】[Brief description of the drawings]

【図1】枝分かれ人工血管の支管間股点Pおよび主管−
支管間股点Q、Q’と力を加える方向を矢印で示した図
である。
FIG. 1 shows a crotch point P between a branch and a main vessel of a branched artificial blood vessel.
It is the figure which showed the crotch points Q and Q 'between branch pipes, and the direction which applies force with an arrow.

【図2】図2(a)は股点P,Qが直角でない枝分かれ
人工血管に例である。図2(b)は側管の直径が主管の
直径より大きい場合、図2(c)は支管が複数の枝分か
れ人工血管の場合を示した図である。
FIG. 2A shows an example of a branched artificial blood vessel in which crotch points P and Q are not right angles. FIG. 2B shows a case where the diameter of the side tube is larger than the diameter of the main tube, and FIG. 2C shows a case where the branch tube is a plurality of branched artificial blood vessels.

【図3】図3はY字形枝分かれ人工血管の場合の股点P
周囲のコーティング範囲を斜線で示した図である。
FIG. 3 shows a crotch point P in the case of a Y-shaped branched artificial blood vessel.
It is the figure which showed the surrounding coating range with the oblique line.

【図4】図4はT字形枝分かれ人工血管の股点P,P’
周囲のコーティング範囲を斜線で示した図である。
FIG. 4 is a crotch point P, P ′ of a T-shaped branched artificial blood vessel.
It is the figure which showed the surrounding coating range with the oblique line.

【図5】図4のD−D断面図であり、コーティング範囲
を点線で示した。
FIG. 5 is a cross-sectional view taken along the line DD of FIG. 4, and a coating range is indicated by a dotted line.

【図6】実施例3、比較例3、実施例4及び比較例4に
おいてコーティング及びその効果を検討した際のコーテ
ィング範囲を斜線で示した図である。
FIG. 6 is a diagram in which hatching indicates the coating range when examining the coating and its effects in Example 3, Comparative Example 3, Example 4, and Comparative Example 4.

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】枝分かれを有する人工血管において、主管
より枝分かれした支管間の股点、あるいは支管と主管と
の付け根の股点を中心に少なくとも支管の直径の範囲内
に高分子弾性体をコーティングすることを特徴とする枝
分かれ人工血管。
In a vascular prosthesis having a branch, a polymer elastic body is coated on at least the range of the diameter of the branch pipe centered on the crotch point between the branch pipes branched from the main pipe or the crotch point at the base of the branch pipe and the main pipe. A branched artificial blood vessel, characterized in that:
【請求項2】高分子弾性体がポリウレタン又はポリシロ
キサンである請求項1記載の枝分かれ人工血管。
2. The branched artificial blood vessel according to claim 1, wherein the elastic polymer is polyurethane or polysiloxane.
JP14375293A 1993-06-15 1993-06-15 Branched artificial blood vessel Expired - Fee Related JP2839126B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14375293A JP2839126B2 (en) 1993-06-15 1993-06-15 Branched artificial blood vessel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14375293A JP2839126B2 (en) 1993-06-15 1993-06-15 Branched artificial blood vessel

Publications (2)

Publication Number Publication Date
JPH07428A JPH07428A (en) 1995-01-06
JP2839126B2 true JP2839126B2 (en) 1998-12-16

Family

ID=15346202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14375293A Expired - Fee Related JP2839126B2 (en) 1993-06-15 1993-06-15 Branched artificial blood vessel

Country Status (1)

Country Link
JP (1) JP2839126B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187033B1 (en) 1997-09-04 2001-02-13 Meadox Medicals, Inc. Aortic arch prosthetic graft
US6439269B1 (en) 2000-06-28 2002-08-27 Burlington Industries, Inc. Room darkener fabric with solution dyed black yarn
JP2007260343A (en) * 2006-03-30 2007-10-11 Terumo Corp Blood vessel prosthetic device

Also Published As

Publication number Publication date
JPH07428A (en) 1995-01-06

Similar Documents

Publication Publication Date Title
US5078735A (en) Prosthetic grafting method for bypass surgery
Tellis et al. Expanded polytetrafluoroethylene graft fistula for chronic hemodialysis.
Seifalian et al. In vivo biostability of a poly (carbonate-urea) urethane graft
Chard et al. Aorta-coronary bypass grafting with polytetrafluoroethylene conduits: early and late outcome in eight patients
US5354329A (en) Vascular prosthesis having enhanced compatibility and compliance characteristics
JP4916159B2 (en) Biological duct stent
Zhang et al. Vascugraft® polyurethane arterial prosthesis as femoro-popliteal and femoro-peroneal bypasses in humans: pathological, structural and chemical analyses of four excised grafts
Blumenberg et al. Failure of knitted Dacron as an arterial prosthesis
Edwards et al. In vitro and in vivo biodurability of a compliant microporous vascular graft
JP2007526797A5 (en)
Yan et al. A new polyurethane/heparin vascular graft for small-caliber vein repair
EP1303232B1 (en) Tube system for reconstructing of urethra
JP2839126B2 (en) Branched artificial blood vessel
WO1988006865A1 (en) Endovascular connector
Lyman et al. Polyurethane elastomers in surgery
JP2842547B2 (en) Bifurcated vascular graft
Davey Aorto-pulmonary fistula due to failure of an Ivalon graft for coarctation of the aorta
Uretzky et al. Long-term evaluation of a new selectively biodegradable vascular graft coated with polyethylene oxide-polylactic acid for right ventricular conduit: an experimental study
Hubaut et al. Mycotic aneurysm of the extracranial carotid artery: an uncommon complication of bacterial endocarditis
Marois et al. A novel microporous polyurethane vascular graft: in vivo evaluation of the UTA prosthesis implanted as infra-renal aortic substitute in dogs
WEILAND et al. Replantation of digits and hands: analysis of surgical techniques and functional results in 71 patients with 86 replantations.
CN113662678B (en) Protective sleeve for preventing stenosis after vascular grafting operation and preparation method thereof
Santiago-Delpin et al. Experimental and clinical use of polytetrafluoroethylene vascular grafts
Komoto et al. Prosthetic aneurysm in an axillofemoral Dacron bypass graft
Benedetti-Valentini et al. Composite grafts for critical ischaemia

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees